Emre Yasar, Yesim Yildiz, Erensu Ozturk, Ebru Gok Oguz, Ezgi Coskun Yenigun, Ramazan Ozturk, Ozant Helvaci, Hasan Selcuk Ozger, Meryem Keles, Cengiz Karacin, Asiye Ugras Dikmen, Kayhan Caglar, Murat Duranay, Mehmet Deniz Ayli, Murat Dizbay, Yasemin Erten, Galip Guz, Ulver Derici
AIM: To evaluate the vaccine response and the effect of the booster dose on COVID-19 positivity in haemodialysis (HD) and peritoneal dialysis (PD) patients who received and did not receive BNT162b2 as a booster dose after two doses of CoronaVac. METHODS: The study included 80 PD and 163 HD patients, who had been administered two doses of the CoronaVac. Antibody levels were measured on Days 42 and 90 after the first dose. Measurements were repeated on Day 181 after the first dose in the patients that received two vaccine doses and on Day 28 after the third dose in those that also received the booster dose...
March 14, 2024: Nephrology